mk 0663 has been researched along with Arthritis, Spinal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feist, J; Murray, A; Schulze-Koops, H; Skapenko, A | 1 |
| Gaidukova, IE; Kirsanova, NV; Nam, IF; Rebrov, AP | 1 |
| Gaydukova, IZ; Rebrov, AP | 1 |
2 trial(s) available for mk 0663 and Arthritis, Spinal
| Article | Year |
|---|---|
[Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis].
Topics: Adolescent; Adult; Cyclooxygenase 2 Inhibitors; Etoricoxib; Humans; Middle Aged; Osteitis; Pyridines; Sacroiliac Joint; Sacroiliitis; Spondylarthritis; Spondylitis, Ankylosing; Sulfones; Treatment Outcome; Young Adult | 2014 |
[Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis].
Topics: Adolescent; Adult; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoricoxib; Female; Humans; Male; Middle Aged; Pyridines; Spondylarthritis; Spondylitis, Ankylosing; Sulfones; Treatment Outcome; Young Adult | 2015 |
1 other study(ies) available for mk 0663 and Arthritis, Spinal
| Article | Year |
|---|---|
A Rare Side Effect of Checkpoint Inhibitor Therapy-Nivolumab-Induced Axial Polyarthritis of the Facet and Costovertebral Joints.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Immunological; Etoricoxib; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Nivolumab; Prednisolone; Range of Motion, Articular; Ribs; Skin Neoplasms; Spondylarthritis; Sternocostal Joints; Treatment Outcome; Zygapophyseal Joint | 2019 |